The GPR40 novel agonist SZZ15-11 improves non-alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet-induced obese mice.
Lei LeiXuefeng GaoJiayu ZhaiShuainan LiuQuan LiuCaina LiHui CaoCunyu FengLeilei ChenLiran LeiXuan PanPingping LiZhanzhu LiuYi HuanZhu-Fang ShenPublished in: Diabetes, obesity & metabolism (2024)
signalling and the AMPK pathway in hepatocytes.